Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p><em>OPRM1</em> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches</p>
Malik Mumtaz Taqi, Muhammad Faisal, Hadar Zaman
Pharmacogenomics and Personalized Medicine (2019) Vol. Volume 12, pp. 361-368
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
Kristine R. Crews, Andrew A. Monte, Rachel Huddart, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 4, pp. 888-896
Open Access | Times Cited: 286
Mutations in G Protein–Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches
Torsten Schöneberg, Ines Liebscher
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 89-119
Open Access | Times Cited: 99
The Skin–Brain Axis: From UV and Pigmentation to Behaviour Modulation
Anna A. Ascsillán, Lajos V. Kemény
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6199-6199
Open Access | Times Cited: 6
Transcriptome Analysis of Trigeminal Ganglion and Medullary Dorsal Horn in Mice to Identify Potential Targets for Pulpitis-Induced Pain
Zhuo Yu, Xiaoning Kang, Jialin Si, et al.
ACS Omega (2025)
Open Access
Morphological condition of the skin following a 4-week opioid exposure in an experimental study
Ivan Diskovskyi, Оrysya Syzon, Lesya R Mateshuk Vatseba, et al.
Wiadomości Lekarskie (2025), Iss. 2, pp. 347-352
Closed Access
Review on application and development of pharmacogenomics of adverse drug reactions
Hongyun Bi, Jun Zhu, Yuanxuan Cai, et al.
Journal of Holistic Integrative Pharmacy (2025) Vol. 6, Iss. 1, pp. 105-116
Open Access
Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder (SUD)
Akshata Y. Patne, Subhra Mohapatra, Shyam S. Mohapatra
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2025) Vol. 17, Iss. 2
Open Access
Codeine and Tramadol Use in Athletes: A Potential for Abuse
Thomas Zandonai, Mónica Escorial, Ana M. Peiró
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27
Reviewing pharmacogenetics to advance precision medicine for opioids
Leen Magarbeh, Ilona Gorbovskaya, Bernard Le Foll, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112060-112060
Open Access | Times Cited: 25
Pharmacogenomics of ketamine: A systematic review
Shakila Meshkat, Nelson B. Rodrigues, Joshua D. Di Vincenzo, et al.
Journal of Psychiatric Research (2021) Vol. 145, pp. 27-34
Closed Access | Times Cited: 25
Prenatal Opioid Exposure Enhances Responsiveness to Future Drug Reward and Alters Sensitivity to Pain: A Review of Preclinical Models and Contributing Mechanisms
Gregory G. Grecco, Brady K. Atwood
eNeuro (2020) Vol. 7, Iss. 6, pp. ENEURO.0393-20.2020
Open Access | Times Cited: 26
Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
Malavika Deodhar, Jacques Turgeon, Véronique Michaud
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1466-1466
Open Access | Times Cited: 21
Modulating Vertebrate Physiology by Genomic Fine-Tuning of GPCR Functions
Torsten Schöneberg
Physiological Reviews (2024) Vol. 105, Iss. 1, pp. 383-439
Closed Access | Times Cited: 1
A Complex Relationship Among the Circadian Rhythm, Reward Circuit and Substance Use Disorder (SUD)
Saptadip Samanta, Debasis Bagchi, Mark S. Gold, et al.
Psychology Research and Behavior Management (2024) Vol. Volume 17, pp. 3485-3501
Open Access | Times Cited: 1
The role of the gut microbiome and microbial metabolism in mediating opioid-induced changes in the epigenome
Udhghatri Kolli, Sabita Roy
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response
Sorina Andreea Anghel, Cristina-Elena Dinu-Pîrvu, Mihaela-Andreea Costache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9371-9371
Open Access | Times Cited: 1
Using pharmacogenetics to structure individual pain management protocols in total knee arthroplasty
William G. Hamilton, Jeanine M. Gargiulo, Nancy L. Parks
The Bone & Joint Journal (2020) Vol. 102-B, Iss. 6_Supple_A, pp. 73-78
Closed Access | Times Cited: 10
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study
Sophia Dobischok, Rebecca Metcalfe, Elizabeth Matzinger, et al.
Patient Preference and Adherence (2022) Vol. Volume 16, pp. 3405-3413
Open Access | Times Cited: 6
Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study
Leen Magarbeh, Ilona Gorbovskaya, Richard Wells, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 918-918
Open Access | Times Cited: 3
Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response
Xiaohu Xie, Jun Gu, Dingding Zhuang, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 5
Trends and implementation of preemptive pharmacogenomic testing
Patrick J. Silva, Kenneth S. Ramos
Elsevier eBooks (2023), pp. 363-381
Closed Access | Times Cited: 2
Identification of a sex-stratified genetic algorithm for opioid addiction risk
David R. Bright, Anna Langerveld, Susan DeVuyst-Miller, et al.
The Pharmacogenomics Journal (2021) Vol. 21, Iss. 3, pp. 326-335
Closed Access | Times Cited: 5
Personalized Medicine Through GPCR Pharmacogenomics
Alexander S. Hauser
Elsevier eBooks (2021), pp. 191-219
Closed Access | Times Cited: 4
Nicotine use disorder and Neuregulin 3: Opportunities for precision medicine
Taylor R. Elder, Jill Turner
Advances in pharmacology (2024), pp. 387-404
Closed Access
The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life
Larisa M. Haupt, Alison Haywood, Heidi G. Sutherland, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top